Emotional Distress Clinical Trial
— N-ACTOfficial title:
Neurobehavioral Affective Control Training (N-ACT): A Randomized Waitlist-controlled Pilot Trial to Evaluate a Novel Transdiagnostic Cognitive Remediation Program for Emotion-related Impulsivity and Rumination
The goal of this clinical trial is to test a new cognitive training program to improve emotion regulation in adults. The investigators' primary aim is to determine whether participating in this program addresses two key features of emotion dysregulation associated with psychiatric disorders: (1) emotion-related impulsivity and (2) rumination. The investigators will further evaluate participants' perceived acceptability and feasibility of treatment procedures. Secondarily, the investigators will examine the effects of this cognitive training intervention on psychiatric symptoms and overall functioning. Participants will be asked to complete eight weekly sessions (over two months) involving cognitive training exercises with a "coach", in addition to a baseline assessment before starting the intervention and post-treatment assessment. Each assessment includes a combination of in-person and remote data collection using self-report questionnaires, psychophysiology, and a neuropsychological battery. Participants will also complete one week of ecological momentary assessment before and after the intervention as well as a set of follow-up questionnaires administered remotely six weeks following their final training session. Researchers will compare participants randomly assigned to complete the intervention without delay to a control group of participants randomly assigned to a two-month waitlist before joining the intervention. Before beginning cognitive training, participants in the control condition will complete an additional pre-intervention/post-waitlist assessment, which will follow parallel procedures to the initial baseline assessment.
Status | Not yet recruiting |
Enrollment | 100 |
Est. completion date | September 2025 |
Est. primary completion date | August 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Current residency in the state of California - Elevated levels of rumination and/or emotion-related impulsivity Exclusion Criteria: - Insufficient English language literacy to understand study procedures (as assessed by self-report) - Careless or inattentive responding as indicated by (a) failing 50% or more of "attention check" items embedded in the online screening questionnaires, (b) overly rapid responding (i.e., mean response time of less than two seconds for multiple choice items), or (c) qualitative review of long strings of identical entries on screening/baseline questionnaire items that suggest data invalidity - Positive history of brain tumors, neurological disorders, or head injuries (with loss of consciousness more than five minutes and/or more than two separate instances of physical trauma) - Recent (i.e., past three months) alcohol/other substance use disorders or current psychosis (as assessed by the Mini International Neuropsychiatric Interview; MINI) - Active suicidal ideation paired with either (1) plan and/or intent or (2) lifetime history of suicide attempts (as assessed by the Columbia Suicide Severity Rating Scale; C-SSRS) |
Country | Name | City | State |
---|---|---|---|
United States | University of California | Berkeley | California |
Lead Sponsor | Collaborator |
---|---|
University of California, Berkeley | University College, London, University of Bergen |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Acceptability | Mean scores on the "Interest/Enjoyment" subscale of the Adapted Intrinsic Motivation Inventory will be used to evaluate the perceived acceptability of the N-ACT program. This self-report index comprises an average of seven items each rated on a 7-point Likert scale (range: 7-49), with larger values indicating greater subjective levels of treatment acceptability. Participants will complete these items during the final intervention session. An average rating of 35 (out of 49) points on this scale will be used as a quantitative "cutoff" score indicating hypothesized adequacy of the intervention's acceptability. | Final (i.e., eighth) N-ACT training session (Week 10 or Week 20 for control arm) | |
Other | Adherence | Attendance rates (i.e., percentages) over the eight weekly N-ACT training sessions will be used to assess adherence to intervention procedures, with larger values reflecting higher levels of treatment adherence and feasibility. The majority of participants (> 66%) across both groups are expected to complete the program by attending all eight sessions. | Final (i.e., eighth) N-ACT training session (Week 10 or Week 20 for control arm) | |
Primary | Emotional Response Inhibition factor score | Raw values on the following behavioral performance-based metrics from the Emotional Stop-Signal Task will be aggregated and standardized via confirmatory factor analysis (CFA): (1a) negative and (1b) positive stop-signal reaction time, measured in milliseconds (larger values indicate worse performance), as well as (2) false alarm probability, represented as percentages (larger values indicate worse performance), on stop-signal trials with (2a) negative and (2b) positive image stimuli. CFA will be used to estimate factor loadings across these four observed indicators and generate Z-scores on a latent composite "Emotional Response Inhibition" variable at each assessment point (re-coded such that larger values reflect superior abilities in this domain). Structural equation modeling of measurement invariance (between groups and over time) will test hypothesized treatment effects on this latent construct, which is expected to increase in magnitude from pre- (T1) to post-intervention (T2). | (1) Baseline (Week 1; T1 for experimental arm); (2) Control arm only: Post-waitlist/pre-intervention (Week 11; T1); (3) Post-treatment (Week 12 or Week 22 for control arm; T2) | |
Primary | Emotional Working Memory factor score | Raw values on the following behavioral performance-based metrics from the Memory and Affective Flexibility Task will be aggregated and standardized via confirmatory factor analysis (CFA): (1) negative and (2) positive working memory recall accuracy rates, represented as percentages (larger values indicate better performance), on trials with (a) target and (b) non-target image stimuli. CFA will be used to estimate factor loadings across these four observed indicators and generate Z-scores on a latent composite "Emotional Working Memory" variable at each assessment point (coded such that larger values reflect superior abilities in this domain). Structural equation modeling of measurement invariance (between groups and over time) will test hypothesized treatment effects on this latent construct, which is expected to increase in magnitude from pre- (T1) to post-intervention (T2). | (1) Baseline (Week 1; T1 for experimental arm); (2) Control arm only: Post-waitlist/pre-intervention (Week 11; T1); (3) Post-treatment (Week 12 or Week 22 for control arm; T2) | |
Primary | Emotion Related-Impulsivity (ERI) | Self-rated "Feelings Trigger Action" scale (range: 1-5; larger values indicate higher levels of this characteristic) of the Three-Factor Impulsivity index as the primary measure of "Emotion-Related Impulsivity" (ERI). This scale will be first administered during the pre-baseline assessment online screening, then again at the pre-intervention assessment session (T1 exclusively for control group participants), as well as during the post-intervention (t2) and follow-up assessments (T3). Structural equation modeling of measurement invariance (between groups and over time) will test hypothesized treatment effects on ERI, which is expected to decrease in magnitude from pre- (T1) to post-intervention (T2/T3). | Pre-baseline screening (Week 0; T1 for experimental arm); (2) Control arm only: Post-waitlist/pre-intervention (Week 11; T1); (3) Post-treatment (Week 12 or Week 22 for control arm; T2); (4) Follow-up (Week 18 or Week 28 for control arm; T3) | |
Primary | Rumination | Self-rated "Brooding" subscale (range: 5-20; larger values indicate higher levels of this characteristic) of the Ruminative Responses Scale as the primary measure of "Rumination" . This subscale will be first administered during the pre-baseline assessment online screening, then at the pre-intervention/post-waitlist assessment session (T1 exclusively for control group participants), then the post-intervention and follow-up (for all participants). Structural equation modeling of measurement invariance (between groups and over time) will test hypothesized treatment effects on Rumination, which is expected to decrease in magnitude from pre- (T1) to post-intervention (T2/T3). | Pre-baseline screening (Week 0; T1 for experimental arm); (2) Control arm only: Post-waitlist/pre-intervention (Week 11; T1); (3) Post-treatment (Week 12 or Week 22 for control arm; T2); (4) Follow-up (Week 18 or Week 28 for control arm; T3) | |
Primary | Emotion Dysregulation factor score | "Emotion Dysregulation" will be a latent construct derived using structural equation modeling of observed scores on the following self-report scales (larger values reflect higher levels of each characteristic): (1) "Pervasive Influence of Feelings" (range: 1-5) from the Three-Factor Impulsivity index; (2) the "Emotion Reactivity Scale" (range: 0-84); (3a) "Anankastia" (range: 0-12) and (3b) "Negative Affectivity" (range: 0-18) from the Personality Inventory for the Diagnostic and Statistical Manual 5th edition Brief Form-Plus; (4) mean change in "Negative Affect" (range: 0-44) from the Positive and Negative Affect Scales over each assessment session; as well as (5a) "Cognitive Reappraisal" (range: 6-36) and (5b) "Expressive Suppression" (range: 4-28) from the "Emotion Regulation Questionnaire". The latent variable will be scored as a Z-score (coded so that larger values reflect more dysregulation), which is hypothesized to decrease from pre- (T1) to post-intervention (T2). | 1) Baseline (Week 1; T1 for experimental arm); (2) Control arm only: Post-waitlist/pre-intervention (Week 11; T1); (3) Post-treatment (Week 12 or Week 22 for control arm; T2) | |
Primary | Externalizing factor score | Externalizing symptoms will comprise a latent variable derived from raw scores on the following self-report scales (larger values reflect greater severity) using confirmatory factor analysis (CFA): (1) the "Adult Attention-Deficit/Hyperactivity Disorder Self-Report Scale" (range: 0-72) plus (2a) "General Externalizing" (range: 0-60), (2b) "Callous Aggression" (range: 0-57) and (2c) "Substance Use" (range: 0-54) from the Externalizing Spectrum Inventory-Revised (ESI-R). CFA will be used to estimate factor loadings across these four observed indicators and generate aggregated, standardized Z-scores on a latent composite "Externalizing" variable at each assessment point (coded such that larger values reflect greater symptom severity). Structural equation modeling of measurement invariance (between groups and over time) will test hypothesized treatment effects on Externalizing psychopathology as a latent construct, which is expected to decrease from pre- (T1) to post-intervention (T2). | 1) Baseline (Week 1; T1 for experimental arm); (2) Control arm only: Post-waitlist/pre-intervention (Week 11; T1); (3) Post-treatment (Week 12 or Week 22 for control arm; T2); (4) ESI-R only: Follow-up (Week 18 or Week 28 for control arm; T3) | |
Primary | Internalizing factor score | Internalizing symptoms will be represented as a latent variable derived from raw scores on the following self-report scales (larger values reflect greater severity) using confirmatory factor analysis (CFA): (1) the "Eating Disorders Examination-Questionnaire" Global scale (range: 0-6) plus (2a) "Distress" (range: 1-5) and (2b) "Fear" (range: 1-5) factor scales from the Inventory of Depression and Anxiety Symptoms (IDAS-II). CFA will be used to estimate factor loadings across these three observed indicators and generate aggregated, standardized Z-scores on a latent composite "Internalizing" variable at each assessment point (coded such that larger values reflect greater symptom severity). Structural equation modeling of measurement invariance (between groups and over time) will test hypothesized treatment effects on Internalizing psychopathology as a latent construct, which is expected to decrease in magnitude from pre- (T1) to post-intervention (T2). | (1) Baseline (Week 1; T1 for experimental arm); (2) Control arm only: Post-waitlist/pre-intervention (Week 11; T1); (3) Post-treatment (Week 12 or Week 22 for control arm; T2); (4) IDAS-II only: Follow-up (Week 18 or Week 28 for control arm; T3) | |
Primary | Functional Impairment factor score | "Functional Impairment" will be represented as latent factor derived from raw scores on two self-rated assessment measures (range: 1-5; larger values reflect higher levels of dysfunction): (1) the Perceived Deficits Questionnaire-Depression, a brief measure of cognitive abilities that are often deleteriously impacted by psychopathology, and (2) the Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form, a survey of general role functioning across core life domains. Observed scores on both indicators will be aggregated via confirmatory factor analysis to derive standardized Z-scores on a latent composite variable at each assessment point (coded such that larger values reflect higher levels of this characteristic). Structural equation modeling of measurement invariance (between groups and over time) will test hypothesized treatment effects on Functional Impairment as a latent construct, which is expected to decrease from pre- (T1) to post-intervention (T2/T3). | (1) Baseline (Week 1; T1 for experimental arm); (2) Control arm only: Post-waitlist/pre-intervention (Week 11; T1); (3) Post-treatment (Week 12 or Week 22 for control arm; T2); (4) IDAS-II only: Follow-up (Week 18 or Week 28 for control arm; T3) | |
Secondary | Affective Flexibility factor score | Raw values on the following behavioral performance-based metrics from the Memory and Affective Flexibility Task switch trials will be aggregated and standardized via confirmatory factor analysis (CFA): (1) negative and (2) positive (a) accuracy rates, represented as percentages (larger values indicate better performance), as well as (b) reaction time, measured in milliseconds (larger values indicate worse performance). CFA will be used to estimate factor loadings across these four observed indicators and generate Z-scores on a latent composite variable at each assessment point (re-coded such that larger values reflect superior abilities in this domain). Structural equation modeling of measurement invariance (between groups and over time) will test hypothesized treatment effects (i.e., "near-transfer" of trained inhibitory processes targeted by N-ACT) on Affective Flexibility as a latent construct, which is expected to increase in magnitude from pre- (T1) to post-intervention (T2). | (1) Baseline (Week 1; T1 for experimental arm); (2) Control arm only: Post-waitlist/pre-intervention (Week 11; T1); (3) Post-treatment (Week 12 or Week 22 for control arm; T2) | |
Secondary | Cold Cognitive Control factor score | Raw values on the following behavioral performance-based metrics from two cold cognitive control tasks will be aggregated and standardized via confirmatory factor analysis (CFA): (1) Estimated Backwards Digit Span recall (i.e., mean span; larger values indicate better performance) and (2) stop-signal reaction time from the traditional (i.e., non-emotional) version of the Stop-Signal Task, measured in milliseconds (larger values indicate worse performance). CFA will be used to estimate factor loadings across these two observed indicators and generate Z-scores on a latent composite variable at each assessment point (re-coded such that larger values reflect superior abilities in this domain). Structural equation modeling of measurement invariance (between groups and over time) will test hypothesized treatment effects (i.e., "far-transfer" of trained inhibitory processes) on this latent construct, which is expected to increase in magnitude from pre- (T1) to post-intervention (T2). | (1) Baseline (Week 1; T1 for experimental arm); (2) Control arm only: Post-waitlist/pre-intervention (Week 11; T1); (3) Post-treatment (Week 12 or Week 22 for control arm; T2) | |
Secondary | Psychophysiological Reactivity factor score | Skin conductance level (SCL) will be monitored during cognitive assessment batteries to assess changes in physiological arousal tied to affective control. Key measurement contrasts include mean SCL microvolt differences between (1a) no-go/stop trials and (1b) go/no-signal trials on the Emotional Stop-Signal Task, as well as (2a) trials on the Memory and Affective Flexibility Task with emotionally-charged stimuli at n-level > 1 versus (2b) trials with ambiguous/neutral stimuli at n-level = 1. Contrast values on these manifest indicators will be aggregated and standardized (to Z-scores) via confirmatory factor analysis to form a latent composite variable at each assessment point (coded such that larger values reflect greater reactivity). Structural equation modeling of measurement invariance (between groups and over time) will test hypothesized treatment effects on this latent construct, which is expected to decrease from pre- (T1) to post-intervention (T2). | (1) Baseline (Week 1; T1 for experimental arm); (2) Control arm only: Post-waitlist/pre-intervention (Week 11; T1); (3) Post-treatment (Week 12 or Week 22 for control arm; T2) | |
Secondary | Daily Emotion Dysregulation factor score | "Daily Emotion Dysregulation" will be represented as a latent variable derived from ecological momentary assessment of key constructs six times daily for one week before and after the N-ACT program. Daily mean scores on the following indices (larger values reflect higher levels of each characteristic) will be aggregated using confirmatory factor analysis: (1) the Momentary Ruminative Self-focus Inventory-Abbreviated (range: 3-21); (2) the Momentary Impulsivity Scale (range: 4-20) during periods of negative affect above person-level mean; as well as (3a) mean and (3b) variability in negative affect (range: 3-15). Structural equation modeling will be used to generate Z-scores on this latent composite variable (re-coded such that larger values reflect higher levels), which is hypothesized to decrease from pre- (T1) to post-intervention (T2). | (1) T1: Baseline (Week 2 for experimental arm) or Post-waitlist/pre-intervention (Week 12 for control arm); and (2) T2: Post-treatment (Week 11 or Week 21 for control arm) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Active, not recruiting |
NCT06035003 -
Mechanism of Mindfulness-Based Online Intervention in Enhancing Cognitive Flexibility
|
N/A | |
Not yet recruiting |
NCT06034613 -
The Effects and Mechanisms of Mindfulness Intervention for Emotional Distress: Daily Interventions and Daily Assessments
|
N/A | |
Enrolling by invitation |
NCT05113706 -
Does Bystanders Emotional State Influence Dispatcher-assisted Cardiopulmonary?Resuscitation
|
||
Not yet recruiting |
NCT06056232 -
Mechanisms of Mindfulness Intervention: Distress Tolerance Dose Manipulation
|
N/A | |
Active, not recruiting |
NCT05600790 -
Mechanism of Mindfulness Based Online Intervention in Reducing Emotional Distress
|
N/A | |
Not yet recruiting |
NCT06103149 -
The Role of Cognitive Flexibility in Mindfulness Intervention: a Functional Near-infrared Spectroscopy Study
|
N/A | |
Completed |
NCT06436521 -
The Efficacy of Online Brief Positive Cognitive Behavior Therapy Compared to Traditional Cognitive Behavior Therapy
|
N/A | |
Not yet recruiting |
NCT06051929 -
Mechanism of Mindfulness Intervention for Emotional Distress: the Role of Cognitive Flexibility
|
N/A | |
Not yet recruiting |
NCT06087484 -
The Effect of Mindfulness Intervention for Emotional Distress of Insomnia People
|
N/A | |
Completed |
NCT05027113 -
App-Based Mindfulness Meditation for People of Color Who Experience Race-Related Stress
|
N/A | |
Not yet recruiting |
NCT06059092 -
Evaluation of Three School-based Mental Health Preventive Interventions in France
|
N/A | |
Enrolling by invitation |
NCT04635618 -
Psychotherapy Strategies for the Treatment of Professionals and Students From Essential Services With High Levels of Emotional Distress in the Context of COVID-19
|
N/A | |
Enrolling by invitation |
NCT04632082 -
Telepsychoeducation for the Prevention of Emotional Distress in Professionals and Students From Essential Services in the Context of COVID-19
|
N/A | |
Completed |
NCT05510635 -
The Effectiveness of Bibliotherapy on Emotional Distress, Coping Strategies and Resilience of Adolescents With Cancer
|
N/A | |
Recruiting |
NCT05639465 -
Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children
|
N/A | |
Completed |
NCT04958941 -
CUIDA-TE, an APP for the Emotional Management
|
N/A | |
Recruiting |
NCT05548699 -
Precision Mental Health in Diabetes - Subtypes of Mental Health, Trajectories, and Patterns With Glycaemic Control
|
||
Completed |
NCT04816708 -
A Self-directed Mobile Mindfulness Intervention to Address Distress and Burnout in Frontline Healthcare Workers
|
N/A | |
Recruiting |
NCT05712057 -
Neurostimulation Versus Therapy for Problems With Emotions
|
N/A |